Call for Abstract

International Conference on Bio-Pharmaceuticals, will be organized around the theme “Novel Strategies and Innovations in Pharmaceutical sciences”

Asia Bio 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Asia Bio 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Drug discovery and design
  • Track 1-2Fundamental drug development
  • Track 1-3Innovations in clinical development
  • Track 1-4Bio pharmaceutics and drug disposition
  • Track 1-5Pharmaceutical technology
  • Track 1-6Radiopharmaceuticals
  • Track 1-7Pharmaceutics and drug delivery
  • Track 2-1Biomarker research, development and technology
  • Track 2-2Disease related and drug related biomarkers
  • Track 2-3Challenges and regulatory approach for biosimilars
  • Track 2-4Clinical studies and clinicians prospects for biosimilars
  • Track 2-5Measurable parameters for customized therapies
  • Track 2-6Future of next generation biosimilars
  • Track 3-1Preformulation in Drug Development
  • Track 3-2Physiological Drug Environment
  • Track 3-3Drug Formulation Considerations
  • Track 3-4Hot Melt Extrusion
  • Track 4-1Analytical IQ, OQ and PQ
  • Track 4-2Modern pharmaceutical analytical techniques
  • Track 4-3Analytical method development and validation
  • Track 4-4Electroanalytical methods
  • Track 4-5Current trends in gravimetric analysis
  • Track 4-6Qualitative & quantitative elemental analysis
  • Track 4-7Qualitative & quantitative elemental analysis
  • Track 4-8Surface characterization techniques for chemical & physical analysis
  • Track 5-1Good clinical practices & good laboratory practices according to ICH
  • Track 5-2Current good manufacturing practices guidelines
  • Track 5-3Management of product storage, transportation and distribution
  • Track 5-4Current regulations and quality standards
  • Track 5-5Quality assurance, quality control and SOP
  • Track 6-1Intellectual property law for generics and innovator rights
  • Track 6-2FDA regulations and compliance strategies
  • Track 6-3Novel strategies for growth in regulatory affairs
  • Track 6-4Regulatory requirements for pharmaceuticals and health care products
  • Track 6-5Intellectual property rights
  • Track 6-6Regulatory issues, quality control and business development
  • Track 6-7Novel strategies for growth in regulatory affairs
  • Track 7-1Pharma waste and its disposal
  • Track 7-2Dispensing pharmacy and research chemists
  • Track 7-3Clinical pharmacy & its key role in treatment
  • Track 7-4Pharmacotherapy
  • Track 7-5Environmental health hazards
  • Track 7-6High performance genetic analysis, fluid dispensing modelling
  • Track 7-7Clinical drug development and therapeutics
  • Track 7-8Environmental health hazards
  • Track 8-1Drug Discovery
  • Track 8-2Pharmaceutical Packaging
  • Track 8-3Quality Assurance and Quality Control
  • Track 8-4Quality by Design and Quality Risk Assessment
  • Track 8-5GMP & cGMP
  • Track 9-1Industrial pharmaceutics
  • Track 9-2Dosage form design, development and manufacturing
  • Track 9-3Post- marketing surveillance
  • Track 9-4Drug discovery and development
  • Track 9-5Clinical studies
  • Track 9-6Marketing
  • Track 10-1Pharmaceutical Nanotechnology based Systems
  • Track 10-2Applications of Pharmaceutical Nanotools
  • Track 10-3Challenges to Pharmaceutical Nanotechnology
  • Track 10-4Advances in self-emulsifying drug delivery systems (SEDDS)
  • Track 10-5Engineering of Pharmaceutical Nano systems
  • Track 10-6Future Prospects of Pharmaceutical Nanotechnology
  • Track 11-1Diagnostic and bioinorganic medicinal chemistry
  • Track 11-2Plant and microbial derived drugs in Drug discovery
  • Track 11-3Recent advances in fluorinated pharmaceuticals based on natural products
  • Track 11-4Green techniques for organic synthesis and medicinal chemistry
  • Track 11-5Current developments in medicinal chemistry
  • Track 11-6Advances in Drug discovery
  • Track 12-1Toxicology studies of plant products
  • Track 12-2Industrial pharmacognosy
  • Track 12-3Drugs from natural sources and its availabity
  • Track 12-4Drug discovery research in pharmacognosy
  • Track 12-5Phytochemistry and phytoconstituents
  • Track 12-6Herbal drugs and its documentation procedures
  • Track 13-1Major challenges in drug delivery systems
  • Track 13-2Preformulation studies and accelerated stability studies
  • Track 13-3Nanotechnology in drug delivery system
  • Track 13-4Lipid drug delivery system
  • Track 13-5Recent advances in targeted drug delivery systems
  • Track 14-1Packaging for Patient Compliance
  • Track 14-2Packing technology for Drug Delivery Systems
  • Track 14-3Serialization implementation challenges for Pharma Companies
  • Track 14-4Regulatory Considerations-China, US, EU, Pharmacopoeia
  • Track 14-5Serialization implementation challenges for Pharma Companies
  • Track 15-1Safety monitoring of medicinal products
  • Track 15-2Drug safety methods
  • Track 15-3Detection of ADR’s and other drug related problems
  • Track 15-4Pharmacoepidemology and drug safety
  • Track 15-5Set up & implementation of cosmetovigilance system
  • Track 15-6Systematic monitoring the safety of cosmetics
  • Track 16-1Radiopharmaceutical Usage
  • Track 16-2Engineering models in biomedicine
  • Track 16-3Clinical laboratory sciences
  • Track 16-4Biomedical data engineering
  • Track 17-1New drug applications and fundamental drug development
  • Track 17-2Scope of contemporary pharmacy practice
  • Track 17-3Ethics in pharmacy and its policies
  • Track 17-4New dimensions of pharmacy practice
  • Track 17-5Clinical laboratory practice
  • Track 17-6Global standards in pharmacy practice
  • Track 18-1Recent advances in neuro and psycho pharmacology
  • Track 18-2Recent toxicological studies and its issues
  • Track 18-3Pharmacoepidemiology and drug safety
  • Track 18-4Current advances in the pharmacology and physiology of trp channels
  • Track 18-5Clinical Pharmacology
  • Track 18-6Pharmacogenetics and pharmacogenomics
  • Track 19-1Drug Repositioning
  • Track 19-2Stages Involved in Drug Development
  • Track 19-3Drug Targeting Systems
  • Track 19-4Clinical Phases
  • Track 19-5Evaluation Techniques